That experience moved Hurley to seek out PrEP, shorthand for preexposure prophylaxis. The antiretroviral medication greatly ...

The FDA approved the first drug, Truvada, back in 2012, and Hurley lives in the San Francisco Bay Area, a place with one of ...

A randomized clinical trial led by Johns Hopkins researchers finds that giving patients a next-day HIV viral load (VL) test ...

TUESDAY, Dec. 23, 2025 (HealthDay News) -- For adults at risk for HIV acquisition or people with HIV (PWH) not taking daily antiretroviral therapy (ART), an HIV viral load (VL) test with next-day ...

At least six children have been found HIV positive in Madhya Pradesh’s Satna allegedly due to contaminated blood transfusions at the district hospital during treatment for thalassaemia, officials said ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

After receiving a series of immunotherapies, most people with HIV in a small study kept their virus levels low for several months—and one person for more than a year and a half—without their usual ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease. Integrase strand ...

The FDA has approved bioLytical Laboratories’ Insti HIV self test. The company touts it as the fastest home-use HIV test available in the U.S., with results in 60 seconds or less. BioLytical said the ...